Ergoteles’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-99
Closed -$142K 1544
2022
Q2
$142K Buy
+99
New +$142K ﹤0.01% 1432
2021
Q4
Sell
-14
Closed -$86K 1227
2021
Q3
$86K Buy
+14
New +$86K ﹤0.01% 1115